Evidence map›Paper›PMID 40277564›Full record

ArticleBiosensors2025

White Light Spectroscopy Characteristics and Expansion Dynamic Behavior of Primary T-Cells: A Possibility of Online, Real-Time, and Sampling-Less CAR T-Cell Production Monitoring.

Bruno Wacogne, Maxime Brito, Clémentine Gamonet, Alain Rouleau, Annie Frelet-Barrand

Abstract read
In one paragraph

Article in Biosensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bruno WacogneCNRS, Institut FEMTO-ST, Université Marie et Louis Pasteur, 25000 Besançon, France.
Maxime BritoEtablissement Français du Sang Bourgogne-Franche Comté (EFS-BFC), 8 Rue Jean-François Xavier Girod, 25000 Besançon, France.
Clémentine GamonetEtablissement Français du Sang Bourgogne-Franche Comté (EFS-BFC), 8 Rue Jean-François Xavier Girod, 25000 Besançon, France.ORCID 0009-0006-4287-2968
Alain RouleauCNRS, Institut FEMTO-ST, Université Marie et Louis Pasteur, 25000 Besançon, France.
Annie Frelet-BarrandCNRS, Institut FEMTO-ST, Université Marie et Louis Pasteur, 25000 Besançon, France.ORCID 0000-0002-0849-9040

Funding

European Regional Development Fund of the Region Bourgogne Franche-Comté BFC000802European Regional Development Fund of the Region Bourgogne Franche-Comté DOS0060162/00
6 · The paper itself

Abstract

The production of advanced therapy medicinal products (ATMP) is a long and highly technical process, resulting in a high cost per dose, which reduces the number of eligible patients. There is a critical need for a closed and sample-free monitoring system to perform the numerous quality controls required. Current monitoring methods are not optimal, mainly because they require the system to be opened up for sampling and result in material losses. White light spectroscopy has emerged as a technique for sample-free control compatible with closed systems. We have recently proposed its use to monitor cultures of CEM-C1 cell lines. In this paper, we apply this method to T-cells isolated from healthy donor blood samples. The main differences between cell lines and human primary T-cells lie in the slightly different shape of their absorption spectra and in the dynamics of cell expansion. T-cells do not multiply exponentially, resulting in a non-constant generation time. Cell expansion is described by a power-law model, which allows for the definition of instantaneous generation times. A correlation between the linear asymptotic behavior of these generation times and the initial cell concentration leads to the hypothesis that this could be an early predictive marker of the final culture concentration. To the best of our knowledge, this is the first time that such concepts have been proposed.

Indexed as

Biosensing TechniquesSpectrum AnalysisT-LymphocytesCell ProliferationHumansLightadvanced therapy medicinal productCAR T-cellcell concentration monitoringquality controlwhite light spectroscopy

Identifiers

PMID40277564
PMCPMC12025026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.